172 related articles for article (PubMed ID: 31623818)
21. Clinically defined subgroups of mycosis fungoides display differing histopathological features at initial biopsy.
Wehkamp U; Weichenthal M; Egberts F; Schwarz T; Klapper W; Oschlies I
Leuk Lymphoma; 2018 Dec; 59(12):2871-2879. PubMed ID: 29616855
[TBL] [Abstract][Full Text] [Related]
22. The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States.
Weinstock MA; Reynes JF
Cancer; 1999 Jan; 85(1):208-12. PubMed ID: 9921994
[TBL] [Abstract][Full Text] [Related]
23. Response to topical corticosteroid monotherapy in mycosis fungoides.
Kartan S; Shalabi D; O'Donnell M; Alpdogan SO; Sahu J; Shi W; Porcu P; Cha J; Nikbakht N
J Am Acad Dermatol; 2021 Mar; 84(3):615-623. PubMed ID: 32428610
[TBL] [Abstract][Full Text] [Related]
24. Mycosis fungoides in young patients: clinical characteristics and outcome.
Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
[TBL] [Abstract][Full Text] [Related]
25. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients.
van Doorn R; Scheffer E; Willemze R
Arch Dermatol; 2002 Feb; 138(2):191-8. PubMed ID: 11843638
[TBL] [Abstract][Full Text] [Related]
26. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
27. Hypopigmented mycosis fungoides versus mycosis fungoides with concomitant hypopigmented lesions: same disease or different variants of mycosis fungoides?
Furlan FC; Pereira BA; Sotto MN; Sanches JA
Dermatology; 2014; 229(3):271-4. PubMed ID: 25323446
[TBL] [Abstract][Full Text] [Related]
28. Papular Mycosis Fungoides Is a Distinctive Variant of Early-stage Mycosis Fungoides: Extended Retrospective Study With Long-term Follow-up.
Saggini A; Fink-Puches R; Cota C; Lora V; Potzinger H; Massone C; Cerroni L
Am J Surg Pathol; 2019 Aug; 43(8):1129-1134. PubMed ID: 30969178
[TBL] [Abstract][Full Text] [Related]
29. Pediatric mycosis fungoides in Singapore: a series of 46 children.
Heng YK; Koh MJ; Giam YC; Tang MB; Chong WS; Tan SH
Pediatr Dermatol; 2014; 31(4):477-82. PubMed ID: 24890628
[TBL] [Abstract][Full Text] [Related]
30. Mycosis Fungoides in Puerto Rico: A 15-year Follow-up Retrospective Study.
Arias-Berrios GE; Falto-Aizpurua L; Figueroa-Guzmán L
P R Health Sci J; 2020 Dec; 39(4):306-310. PubMed ID: 33320459
[TBL] [Abstract][Full Text] [Related]
31. [Papular mycosis fungoides].
Brajon D; Bonnet N; Dales JP; Berbis P
Ann Dermatol Venereol; 2013; 140(6-7):455-8. PubMed ID: 23773745
[TBL] [Abstract][Full Text] [Related]
32. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.
Lebowitz E; Geller S; Flores E; Pulitzer M; Horwitz S; Moskowitz A; Kheterpal M; Myskowski PL
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):108-114. PubMed ID: 30176169
[TBL] [Abstract][Full Text] [Related]
33. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
Kim YH; Chow S; Varghese A; Hoppe RT
Arch Dermatol; 1999 Jan; 135(1):26-32. PubMed ID: 9923777
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases.
Benner MF; Jansen PM; Vermeer MH; Willemze R
Blood; 2012 Feb; 119(7):1643-9. PubMed ID: 22160616
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
37. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
38. Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008.
Nath SK; Yu JB; Wilson LD
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):419-23. PubMed ID: 24508350
[TBL] [Abstract][Full Text] [Related]
39. Delay in the histopathologic diagnosis of mycosis fungoides.
Skov AG; Gniadecki R
Acta Derm Venereol; 2015 Apr; 95(4):472-5. PubMed ID: 25228392
[TBL] [Abstract][Full Text] [Related]
40. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
